Rgenta Therapeutics, Inc. — Form D/A
Rgenta Therapeutics, Inc. of Woburn, MA, a company, filed a Form D amendment with the SEC on 2021-03-12. The offering totals $38.0M, of which $10.0M was reported sold. Industry: Other.
Offering
- Filed: 2021-03-12
- Form: D/A
- Accession: 0001801266-21-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $38.0M
- Amount sold: $10.0M
- Remaining: $28.0M
- Investors: 6
- Date of first sale: 2020-01-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-359879
Issuer
- Name: Rgenta Therapeutics, Inc.
- CIK: 0001801266
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 300 TradeCenter, Suite 6600, Woburn, MA, 01801
- Phone: 781-608-3996
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Martin Simon Heidecker | Director | Cambridge, MA |
| Judith Simon Li | Director | Woburn, MA |
| Sun Simon Linghao | Director | Woburn, MA |
| Hualin Simon Xi | Director | Woburn, MA |
| Hualin Simon Xi | Executive Officer | Woburn, MA |
| Fei Simon Shen | Director | Woburn, MA |
| Debasish Simon Roychowdhury | Director | Woburn, MA |
| Hongbo Simon Lu | Director | Woburn, MA |
| Travis Simon Wager | Executive Officer | Woburn, MA |
| Zhiping Simon Weng | Director | Woburn, MA |
Other filings by this issuer (2)
More